These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10957683)

  • 41. The inheritance of Alzheimer's disease: a new interpretation.
    Fitch N; Becker R; Heller A
    Ann Neurol; 1988 Jan; 23(1):14-9. PubMed ID: 2964224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twin studies of Alzheimer disease: II. Some predictions under a genetic model.
    Breitner JC; Murphy EA
    Am J Med Genet; 1992 Nov; 44(5):628-34. PubMed ID: 1481823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two new approaches toward linkage heterogeneity of FAD: two-locus models and age of onset as a discriminator.
    Mérette C; Lehner T; Ott J
    Genet Epidemiol; 1993; 10(6):455-9. PubMed ID: 8314043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Werner's syndrome and familial Alzheimer's disease].
    Miki T; Nakura J; Kamino K; Ogihara T
    Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):366-73. PubMed ID: 8098160
    [No Abstract]   [Full Text] [Related]  

  • 45. Early diagnosis and the clinical genetics of Alzheimer's disease.
    Lovestone S
    J Neurol; 1999 Feb; 246(2):69-72. PubMed ID: 10195399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Segregation analysis of Alzheimer pedigrees: rare Mendelian dominant mutation(s) explain a minority of early-onset cases. French Alzheimer Collaborative Group.
    Martinez M; Campion D; Babron MC; Hannequin D; Agid Y; Bellis M; Brice A; Mallet J; Michon A; Thomas-Anterion C; Clerget-Darpoux F
    Am J Med Genet; 1996 Feb; 67(1):9-12. PubMed ID: 8678122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening of the mis-sense mutation producing the 717Val-->Ile substitution in the amyloid precursor protein in Japanese familial and sporadic Alzheimer's disease.
    Yoshizawa T; Komatsuzaki Y; Iwamoto H; Mizusawa H; Kanazawa I
    J Neurol Sci; 1993 Jul; 117(1-2):12-5. PubMed ID: 8410047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The amyloid precursor protein locus and very-late-onset Alzheimer disease.
    Olson JM; Goddard KA; Dudek DM
    Am J Hum Genet; 2001 Oct; 69(4):895-9. PubMed ID: 11500807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linkage analysis in familial Alzheimer disease: description of the Duke and Boston data sets.
    Pericak-Vance MA; St George-Hyslop PH; Gaskell PC; Growdon J; Crain BJ; Hulette C; Gusella JF; Yamaoka L; Tanzi RE; Roses AD
    Genet Epidemiol; 1993; 10(6):361-4. PubMed ID: 8314027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic determinants of Alzheimer disease.
    St George-Hyslop P
    Prog Clin Biol Res; 1995; 393():139-45. PubMed ID: 8545447
    [No Abstract]   [Full Text] [Related]  

  • 51. Chromosome 14 and late-onset familial Alzheimer disease (FAD).
    Schellenberg GD; Payami H; Wijsman EM; Orr HT; Goddard KA; Anderson L; Nemens E; White JA; Alonso ME; Ball MJ
    Am J Hum Genet; 1993 Sep; 53(3):619-28. PubMed ID: 8352272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the amyloid precursor protein locus on dementia in Down syndrome.
    Margallo-Lana M; Morris CM; Gibson AM; Tan AL; Kay DW; Tyrer SP; Moore BP; Ballard CG
    Neurology; 2004 Jun; 62(11):1996-8. PubMed ID: 15184603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Family with 22-derived marker chromosome and late-onset dementia of the Alzheimer type: I. Application of a new model for estimation of the risk of disease associated with the marker.
    Percy ME; Markovic VD; Crapper McLachlan DR; Berg JM; Hummel JT; Laing ME; Dearie TG; Andrews DF
    Am J Med Genet; 1991 Jun; 39(3):307-13. PubMed ID: 1867282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic studies on an Alzheimer clinic population.
    Sadovnick AD; Irwin ME; Baird PA; Beattie BL
    Genet Epidemiol; 1989; 6(5):633-43. PubMed ID: 2591733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer disease prevention: focus on cardiovascular risk, not amyloid?
    Geldmacher DS
    Cleve Clin J Med; 2010 Oct; 77(10):689-704. PubMed ID: 20889807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for dementia in people with down syndrome: issues in assessment and diagnosis.
    Bush A; Beail N
    Am J Ment Retard; 2004 Mar; 109(2):83-97. PubMed ID: 15000668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Technical feasibility of genetic testing for Alzheimer's disease.
    Mullan M; Crawford F; Buchanan J
    Alzheimer Dis Assoc Disord; 1994; 8(2):102-15. PubMed ID: 8060603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The genetics of Alzheimer's disease.
    Schellenberg GD; Bird TD; Wijsman EM; Moore DK; Martin GM
    Biomed Pharmacother; 1989; 43(7):463-8. PubMed ID: 2531010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.
    Conidi ME; Bernardi L; Puccio G; Smirne N; Muraca MG; Curcio SA; Colao R; Piscopo P; Gallo M; Anfossi M; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Cupidi C; Torchia G; Di Lorenzo R; Mandich P; Confaloni A; Maletta RG; Bruni AC
    Neurology; 2015 Jun; 84(22):2266-73. PubMed ID: 25948718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic dissection of Alzheimer disease, a heterogeneous disorder.
    Schellenberg GD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8552-9. PubMed ID: 7567974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.